18 | NociceptinIBA
01/2023
-
02/2002 |
13 | Peptides (Polypeptides)IBA
01/2022
-
11/2002 |
10 | Proteins (Proteins, Gene)FDA Link
12/2022
-
11/2002 |
7 | Thymidylate SynthaseIBA
12/2022
-
08/2011 |
7 | NeuropeptidesIBA
01/2021
-
10/2005 |
7 | LigandsIBA
03/2017
-
01/2002 |
5 | (Nphe(1),Arg(14),Lys(15))N-OFQ NH(2)IBA
01/2017
-
05/2005 |
4 | Nociceptin ReceptorIBA
01/2023
-
11/2006 |
4 | EnzymesIBA
12/2022
-
08/2011 |
4 | Anti-Anxiety Agents (Anxiolytics)IBA
03/2017
-
12/2008 |
3 | LipopolysaccharidesIBA
01/2023
-
01/2013 |
3 | Opioid Receptors (Opioid Receptor)IBA
01/2017
-
11/2015 |
3 | Oxidopamine (6 Hydroxydopamine)IBA
06/2014
-
10/2005 |
3 | Opioid Analgesics (Opioids)IBA
01/2013
-
02/2002 |
3 | Capsaicin (Zostrix)FDA Link
02/2010
-
03/2005 |
2 | Peptidoglycan (Murein)IBA
01/2023
-
01/2022 |
2 | Fluorouracil (Carac)FDA LinkGeneric
12/2022
-
09/2019 |
2 | Growth InhibitorsIBA
09/2019
-
12/2014 |
2 | PlatinumIBA
09/2019
-
08/2011 |
2 | Amyloid (Amyloid Fibrils)IBA
01/2018
-
11/2002 |
2 | Analgesics (Analgesic Drugs)IBA
03/2017
-
08/2016 |
2 | 6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA
01/2017
-
08/2016 |
2 | Morphine (MS Contin)FDA LinkGeneric
11/2015
-
01/2010 |
2 | Opioid Peptides (Opioid Peptide)IBA
11/2015
-
01/2002 |
2 | Nphe(1)- (pF)Phe(4)- Aib(7)- Arg(14)- Lys(15)- nociceptin-amideIBA
11/2015
-
01/2010 |
2 | Cisplatin (Platino)FDA LinkGeneric
11/2014
-
08/2011 |
2 | fluorescein isothiocyanate bovine serum albuminIBA
01/2013
-
11/2007 |
2 | Prion ProteinsIBA
08/2012
-
09/2005 |
2 | delta Opioid Receptors (delta Opioid Receptor)IBA
07/2004
-
12/2002 |
2 | 2',6'- dimethyltyrosyl- 1,2,3,4- tetrahydroisoquinoline- 3- carboxylic acidIBA
07/2004
-
12/2002 |
2 | AcidsIBA
12/2002
-
01/2002 |
1 | Imiquimod (Aldara)FDA LinkGeneric
01/2023 |
1 | SulfonamidesIBA
01/2023 |
1 | InflammasomesIBA
01/2023 |
1 | OvalbuminIBA
01/2023 |
1 | Small Cytoplasmic RNAIBA
01/2023 |
1 | ProdrugsIBA
12/2022 |
1 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2022 |
1 | Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
12/2022 |
1 | Tadalafil (Cialis)FDA Link
01/2022 |
1 | Guanosine Monophosphate (5' Guanylic Acid)IBA
01/2022 |
1 | Vardenafil Dihydrochloride (Levitra)FDA Link
01/2022 |
1 | Sildenafil Citrate (Viagra)FDA Link
01/2022 |
1 | diethylstilbestrol monophosphate (PDES)IBA
01/2022 |
1 | Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
01/2022 |
1 | Amyloid Precursor Protein Secretases (beta-Secretase)IBA
11/2021 |
1 | T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
05/2021 |
1 | B-Lymphocyte Epitopes (B-Cell Epitope)IBA
05/2021 |
1 | Protein Subunit VaccinesIBA
05/2021 |
1 | Antitussive Agents (Antitussives)FDA Link
01/2021 |
1 | Folic Acid (Vitamin M)FDA LinkGeneric
01/2021 |
1 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2021 |
1 | GlobinsIBA
10/2020 |
1 | Small Molecule LibrariesIBA
10/2020 |
1 | Fetal Hemoglobin (Hemoglobin F)IBA
10/2020 |
1 | Cyclic PeptidesIBA
09/2019 |
1 | Explosive Agents (Explosives)IBA
01/2019 |
1 | ZP120IBA
01/2019 |
1 | Proline (L-Proline)FDA Link
01/2018 |
1 | Nootropic Agents (Nootropics)IBA
03/2017 |
1 | CannabinoidsIBA
11/2016 |
1 | hemopressinIBA
11/2016 |